Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer.

Karass M, Bareja R, Shelkey E, Vlachostergios PJ, Robinson BD, Khani F, Mosquera JM, Scherr DS, Sboner A, Tagawa ST, Molina AM, Elemento O, Nanus DM, Faltas BM.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):194-200. doi: 10.6004/jnccn.2018.7264.

PMID:
30865916
2.

Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?

Taylor BL, Matrai CE, Smith AL, Ayangbesan A, Xia L, Golombos DM, Mosquera JM, Nicolas J, Robinson BD, Scherr DS, Khani F.

Clin Genitourin Cancer. 2019 Feb;17(1):e209-e215. doi: 10.1016/j.clgc.2018.10.009. Epub 2018 Oct 29.

PMID:
30470630
3.

Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy.

Moschini M, Soria F, Mathieu R, Xylinas E, D'Andrea D, Tan WS, Kelly JD, Simone G, Tuderti G, Meraney A, Krishna S, Konety B, Zamboni S, Baumeister P, Mattei A, Briganti A, Montorsi F, Galucci M, Rink M, Karakiewicz PI, Rouprêt M, Aziz A, Perry M, Rowe E, Koupparis A, Kassouf W, Scherr DS, Ploussard G, Boorjian SA, Sooriakumaran P, Shariat SF; European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group.

Urol Oncol. 2019 Mar;37(3):179.e1-179.e7. doi: 10.1016/j.urolonc.2018.10.012. Epub 2018 Nov 14.

PMID:
30446442
4.

Urinary pH and the risk of recurrence in patients with non-muscle invasive bladder cancer.

Stone BV, Ayangbesan A, Taylor BL, Golombos DM, Lewicki P, Al Hussein Al Awamlh B, O'Malley P, Kaplan SA, Scherr DS, Chughtai B.

Can J Urol. 2018 Aug;25(4):9407-9412.

PMID:
30125520
5.

Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses.

Ayangbesan A, Golombos DM, Golan R, O'Malley P, Lewicki P, Wu X, Scherr DS.

J Endourol. 2019 Jan;33(1):50-60. doi: 10.1089/end.2018.0144.

PMID:
29914269
6.

Concurrent Inguinal Hernia Repair in Patients Undergoing Minimally Invasive Radical Prostatectomy: A National Surgical Quality Improvement Program Study.

Xia L, Taylor BL, Patel NA, Chelluri RR, Raman JD, Scherr DS, Guzzo TJ.

J Endourol. 2018 Jul;32(7):665-670. doi: 10.1089/end.2018.0210. Epub 2018 Jun 14.

PMID:
29717658
7.

Robotic Nephroureterectomy.

Taylor BL, Scherr DS.

Urol Clin North Am. 2018 May;45(2):189-197. doi: 10.1016/j.ucl.2017.12.004. Epub 2018 Feb 21. Review.

PMID:
29650135
8.

Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Tilki D, Chandrasekar T, Capitanio U, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Lorentz A, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vera-Donoso C, Zigeuner R, Libertino JA, Evans CP.

Urol Oncol. 2018 Feb;36(2):79.e11-79.e17. doi: 10.1016/j.urolonc.2017.10.008. Epub 2017 Nov 10.

PMID:
29129353
9.

Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study.

Malte R, Kluth LA, Kaushik D, Boorjian SA, Abufaraj M, Foerster B, Rink M, Gust K, Roghmann F, Noldus J, Vordos D, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Karakiewicz PI, Rouprêt M, Briganti A, Scherr DS, Shariat SF, Seebacher V.

Eur J Surg Oncol. 2017 Nov;43(11):2193-2199. doi: 10.1016/j.ejso.2017.08.013. Epub 2017 Sep 7.

PMID:
28928012
10.

The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study.

Golombos DM, Ayangbesan A, O'Malley P, Lewicki P, Barlow L, Barbieri CE, Chan C, DuLong C, Abu-Ali G, Huttenhower C, Scherr DS.

Urology. 2018 Jan;111:122-128. doi: 10.1016/j.urology.2017.08.039. Epub 2017 Sep 6.

PMID:
28888753
11.

Improving Self-Efficacy and Self-Care in Adult Patients With a Urinary Diversion: A Pilot Study.

Merandy K, Morgan MA, Lee R, Scherr DS.

Oncol Nurs Forum. 2017 May 1;44(3):E90-E100. doi: 10.1188/17.ONF.E90-E100.

12.

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

Sanda MG, Feng Z, Howard DH, Tomlins SA, Sokoll LJ, Chan DW, Regan MM, Groskopf J, Chipman J, Patil DH, Salami SS, Scherr DS, Kagan J, Srivastava S, Thompson IM Jr, Siddiqui J, Fan J, Joon AY, Bantis LE, Rubin MA, Chinnayian AM, Wei JT; and the EDRN-PCA3 Study Group, Bidair M, Kibel A, Lin DW, Lotan Y, Partin A, Taneja S.

JAMA Oncol. 2017 Aug 1;3(8):1085-1093. doi: 10.1001/jamaoncol.2017.0177.

13.

Minimally invasive vs open nephrectomy in the modern era: does approach matter?

Golombos DM, Chughtai B, Trinh QD, Thomas D, Mao J, Te A, O'Malley P, Scherr DS, Del Pizzo J, Hu JC, Sedrakyan A.

World J Urol. 2017 Oct;35(10):1557-1568. doi: 10.1007/s00345-017-2040-6. Epub 2017 May 5.

PMID:
28477204
14.

Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.

O'Malley PG, Nguyen DP, Al Hussein Al Awamlh B, Wu G, Thompson IM, Sanda M, Rubin M, Wei JT, Lee R, Christos P, Barbieri C, Scherr DS.

J Urol. 2017 Jul;198(1):42-49. doi: 10.1016/j.juro.2017.01.058. Epub 2017 Jan 20.

15.

The Camey Procedure.

Scherr DS.

J Urol. 2017 Feb;197(2S):S180-S181. doi: 10.1016/j.juro.2016.10.115. Epub 2016 Dec 20. No abstract available.

PMID:
28010974
16.

The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy.

Golombos DM, O'Malley P, Lewicki P, Nguyen DP, Stone BV, Al Hussein Al Awamlh B, Scherr DS.

World J Urol. 2017 Jul;35(7):1063-1071. doi: 10.1007/s00345-016-1972-6. Epub 2016 Nov 19.

PMID:
27866245
17.

Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial.

Lewicki P, Shoag J, Golombos DM, Oromendia C, Ballman KV, Halpern JA, Stone BV, O'Malley P, Barbieri CE, Scherr DS.

J Urol. 2017 Apr;197(4):1014-1019. doi: 10.1016/j.juro.2016.11.002. Epub 2016 Nov 8.

PMID:
27836710
18.

Adoption of Technology and Its Impact on Nephrectomy Outcomes, a U.S. Population-Based Analysis (2008-2012).

Golombos DM, Chughtai B, Trinh QD, Mao J, Te A, O'Malley P, Scherr DS, Del Pizzo J, Hu JC, Sedrakyan A.

J Endourol. 2017 Jan;31(1):91-99. doi: 10.1089/end.2016.0643. Epub 2016 Nov 30.

PMID:
27809567
19.

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.

Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA, McKiernan JM, Libertino JA, Haferkamp A; International Renal Cell Carcinoma-Venous Thrombus Consortium, Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, O'Malley P, Pahernik S, Palou J, Moreno JL, Pruthi RS, Faba OR, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso CV, Vergho D, Wallen EM, Zigeuner R.

J Surg Oncol. 2016 Nov;114(6):764-768. doi: 10.1002/jso.24395. Epub 2016 Aug 26.

20.

Factors Impacting the Occurrence of Local, Distant and Atypical Recurrences after Robot-Assisted Radical Cystectomy: A Detailed Analysis of 310 Patients.

Nguyen DP, Al Hussein Al Awamlh B, O'Malley P, Khan F, Lewicki PJ, Golombos DM, Scherr DS.

J Urol. 2016 Nov;196(5):1390-1396. doi: 10.1016/j.juro.2016.05.101. Epub 2016 May 31.

PMID:
27259653
21.

A Prospective Randomized Trial of the Effects of Early Enteral Feeding After Radical Cystectomy.

Deibert CM, Silva MV, RoyChoudhury A, McKiernan JM, Scherr DS, Seres D, Benson MC.

Urology. 2016 Oct;96:69-73. doi: 10.1016/j.urology.2016.06.045. Epub 2016 Jul 8.

PMID:
27402372
22.

Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer.

Nguyen DP, O'Malley P, Al Hussein Al Awamlh B, Furrer MA, Mongan NP, Robinson BD, Wang GJ, Scherr DS.

Clin Genitourin Cancer. 2017 Apr;15(2):256-262.e1. doi: 10.1016/j.clgc.2016.05.017. Epub 2016 May 27.

PMID:
27324053
23.

Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.

Golombos DM, O'Malley P, Lewicki P, Stone BV, Scherr DS.

BJU Int. 2017 Jan;119(1):128-134. doi: 10.1111/bju.13535. Epub 2016 Jun 15.

24.

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest.

Lau C, O'Malley P, Gaudino M, Scherr DS, Girardi LN.

Ann Thorac Surg. 2016 Sep;102(3):836-842. doi: 10.1016/j.athoracsur.2016.03.012. Epub 2016 May 10.

PMID:
27173070
25.

Magnetic resonance microscopy may enable distinction between normal histomorphological features and prostate cancer in the resected prostate gland.

Durand M, Jain M, Robinson B, Aronowitz E, El Douahy Y, Leung R, Scherr DS, Ng A, Donzeau D, Amiel J, Spincemaille P, Villers A, Ballon DJ.

BJU Int. 2017 Mar;119(3):414-423. doi: 10.1111/bju.13523. Epub 2016 Jun 1.

26.

Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study.

Hu JC, Chughtai B, O'Malley P, Halpern JA, Mao J, Scherr DS, Hershman DL, Wright JD, Sedrakyan A.

Eur Urol. 2016 Jul;70(1):195-202. doi: 10.1016/j.eururo.2016.03.028. Epub 2016 Apr 28.

PMID:
27133087
27.

The safety of robot-assisted cystectomy in patients with previous history of pelvic irradiation.

Al Hussein Al Awamlh B, Nguyen DP, Otto B, O'Malley P, Khan F, Brooks S, Scherr DS.

BJU Int. 2016 Sep;118(3):437-43. doi: 10.1111/bju.13464. Epub 2016 Apr 2.

28.

Multiphoton microscopy for rapid histopathological evaluation of kidney tumours.

Jain M, Robinson BD, Aggarwal A, Shevchuk MM, Scherr DS, Mukherjee S.

BJU Int. 2016 Jul;118(1):118-26. doi: 10.1111/bju.13377. Epub 2015 Dec 14.

29.

Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.

Mathieu R, Klatte T, Margulis V, Karam JA, Rouprêt M, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Rink M, Kluth LA, Scherr DS, Robinson BD, Shariat SF.

Urol Oncol. 2015 Nov;33(11):495.e15-22. doi: 10.1016/j.urolonc.2015.06.016. Epub 2015 Jul 27.

PMID:
26228160
30.

Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study.

Mathieu R, Klatte T, Lucca I, Mbeutcha A, Seitz C, Karakiewicz PI, Fajkovic H, Sun M, Lotan Y, Scherr DS, Montorsi F, Briganti A, Rouprêt M, Margulis V, Rink M, Kluth LA, Rieken M, Kenner L, Susani M, Robinson BD, Xylinas E, Loidl W, Shariat SF.

BJU Int. 2016 Aug;118(2):243-9. doi: 10.1111/bju.13224. Epub 2015 Aug 13.

32.

Reply: To PMID 26142590.

Nguyen DP, Al Hussein Al Awamlh B, Scherr DS.

Urology. 2015 Jul;86(1):107. doi: 10.1016/j.urology.2015.02.063. No abstract available.

PMID:
26142592
33.

Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications.

Nguyen DP, Al Hussein Al Awamlh B, Faltas BM, O'Malley P, Ayangbesan A, Inoyatov IM, Scherr DS.

Urology. 2015 Jul;86(1):99-106. doi: 10.1016/j.urology.2015.02.061.

PMID:
26142590
34.

Multiphoton microscopy: a potential intraoperative tool for the detection of carcinoma in situ in human bladder.

Jain M, Robinson BD, Shevchuk MM, Aggarwal A, Salamoon B, Dubin JM, Scherr DS, Mukherjee S.

Arch Pathol Lab Med. 2015 Jun;139(6):796-804. doi: 10.5858/arpa.2014-0076-OA.

PMID:
26030249
35.

Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.

Raza SJ, Wilson T, Peabody JO, Wiklund P, Scherr DS, Al-Daghmin A, Dibaj S, Khan MS, Dasgupta P, Mottrie A, Menon M, Yuh B, Richstone L, Saar M, Stoeckle M, Hosseini A, Kaouk J, Mohler JL, Rha KH, Wilding G, Guru KA.

Eur Urol. 2015 Oct;68(4):721-8. doi: 10.1016/j.eururo.2015.04.021. Epub 2015 May 16.

PMID:
25985883
36.

Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.

Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Espinós EL, Mandel P, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

J Urol. 2015 Aug;194(2):304-308. doi: 10.1016/j.juro.2015.02.2948. Epub 2015 Mar 19.

37.

Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer.

Nguyen DP, Al Hussein Al Awamlh B, Wu X, O'Malley P, Inoyatov IM, Ayangbesan A, Faltas BM, Christos PJ, Scherr DS.

Eur Urol. 2015 Sep;68(3):399-405. doi: 10.1016/j.eururo.2015.02.003. Epub 2015 Feb 20.

38.

Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.

de la Calle C, Patil D, Wei JT, Scherr DS, Sokoll L, Chan DW, Siddiqui J, Mosquera JM, Rubin MA, Sanda MG.

J Urol. 2015 Jul;194(1):65-72. doi: 10.1016/j.juro.2015.01.091. Epub 2015 Jan 28.

39.

Assessment of the quality-of-life and functional outcomes in patients undergoing cystectomy and urinary diversion for the management of radiation-induced refractory benign disease.

Al Hussein Al Awamlh B, Lee DJ, Nguyen DP, Green DA, Shariat SF, Scherr DS.

Urology. 2015 Feb;85(2):394-400. doi: 10.1016/j.urology.2014.08.047.

PMID:
25623700
40.

Prostate cancer risk estimation tool use by members of the American Urological Association: a survey based study.

Otto BJ, Osterberg EC, Salgado S, Scherr DS, Shariat SF.

J Urol. 2015 Jun;193(6):1933-7. doi: 10.1016/j.juro.2014.12.090. Epub 2015 Jan 3.

PMID:
25562444
41.

Postoperative complications and short-term oncological outcomes of patients aged ≥80 years undergoing robot-assisted radical cystectomy.

Nguyen DP, Al Hussein Al Awamlh B, Charles Osterberg E, Chrystal J, Flynn T, Lee DJ, Scherr DS.

World J Urol. 2015 Sep;33(9):1315-21. doi: 10.1007/s00345-014-1446-7. Epub 2014 Nov 20.

PMID:
25410374
42.

Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.

Mathieu R, Shariat SF, Seitz C, Karakiewicz PI, Fajkovic H, Sun M, Lotan Y, Scherr DS, Tewari A, Montorsi F, Briganti A, Rouprêt M, Lucca I, Margulis V, Rink M, Kluth LA, Rieken M, Bachman A, Xylinas E, Robinson BD, Bensalah K, Margreiter M.

World J Urol. 2015 Aug;33(8):1165-71. doi: 10.1007/s00345-014-1421-3. Epub 2014 Oct 26.

PMID:
25344896
43.

Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?

Al Hussein Al Awamlh B, Wang LC, Nguyen DP, Rieken M, Lee RK, Lee DJ, Flynn T, Chrystal J, Shariat SF, Scherr DS.

BJU Int. 2015 Nov;116(5):805-14. doi: 10.1111/bju.12919. Epub 2015 May 11.

44.

Conditional survival after radical nephroureterectomy for upper tract carcinoma.

Ploussard G, Xylinas E, Lotan Y, Novara G, Margulis V, Rouprêt M, Matsumoto K, Karakiewicz PI, Montorsi F, Remzi M, Seitz C, Scherr DS, Kapoor A, Fairey AS, Rendon R, Izawa J, Black PC, Lacombe L, Shariat SF, Kassouf W.

Eur Urol. 2015 Apr;67(4):803-12. doi: 10.1016/j.eururo.2014.08.003. Epub 2014 Aug 19.

PMID:
25145551
45.

International Robotic Radical Cystectomy Consortium: A way forward.

Raza SJ, Field E, Kibel AS, Mottrie A, Weizer AZ, Wagner A, Hemal AK, Scherr DS, Schanne F, Gaboardi F, Wu G, Peabody JO, Koauk J, Redorta JP, Pattaras JG, Rha KH, Richstone L, Balbay MD, Menon M, Hayn M, Stoeckle M, Wiklund P, Dasgupta P, Pruthi R, Ghavamian R, Khan S, Siemer S, Maatman T, Wilson T, Poulakis V, Wilding G, Guru KA.

Indian J Urol. 2014 Jul;30(3):314-7. doi: 10.4103/0970-1591.134253.

49.

Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder.

Wang LC, Xylinas E, Kent MT, Kluth LA, Rink M, Jamzadeh A, Rieken M, Al Hussein Al Awamlh B, Trinh QD, Sun M, Karakiewicz PI, Novara G, Chrystal J, Zerbib M, Scherr DS, Lotan Y, Vickers A, Shariat SF.

Urol Oncol. 2014 May;32(4):433-40. doi: 10.1016/j.urolonc.2013.10.015. Epub 2014 Jan 13.

PMID:
24433754
50.

Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.

Klatte T, Xylinas E, Rieken M, Kluth LA, Rouprêt M, Pycha A, Fajkovic H, Seitz C, Karakiewicz PI, Lotan Y, Babjuk M, de Martino M, Scherr DS, Shariat SF.

J Urol. 2014 May;191(5):1238-43. doi: 10.1016/j.juro.2013.11.106. Epub 2013 Dec 11.

PMID:
24333243

Supplemental Content

Loading ...
Support Center